Ticagrelor
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Cardiac & Hypertension treatment.
🧴 Clinical Application
Take orally twice daily (every 12 hours) with water, with or without food. Co-administered with low-dose aspirin (75-100 mg daily). Do not miss doses due to reversible binding.
⚠️ Side Effects
Common: Dyspnea (shortness of breath, usually self-limiting), bleeding, bruising, epistaxis, hyperuricemia. Rare/Severe: Boxed warnings: Bleeding risk (can be fatal); reduced effectiveness when co-administered with maintenance aspirin doses > 100 mg daily; ventricular pauses, and intracranial hemorrhage.
🛡️ Safety Warnings
Black box warnings: (1) Major fatal bleeding; (2) Maintenance aspirin doses above 100 mg decrease the clinical efficacy of ticagrelor; co-administer ONLY with low-dose aspirin (75-100 mg). Contraindicated in active pathological bleeding and history of intracranial hemorrhage.
Jan Aushadhi Products containing Ticagrelor
Found 2 generic formulation(s) containing this active ingredient.
Ticagrelor Tablets 90 mg
Ticagrelor is a direct-acting, reversibly-binding cyclopentyltriazolopyrimidine P2Y12 platelet antagonist on the WHO Model List of Essential Medicines. Unlike thienopyridines (clopidogrel, prasugrel), it does not require metabolic bioactivation, offering rapid, predictable, and reversible platelet inhibition. Indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (ACS) or a history of myocardial infarction and high risk of developing an atherothrombotic event.
Ticagrelor Tablets 60mg
Ticagrelor is a direct-acting, reversibly-binding cyclopentyltriazolopyrimidine P2Y12 platelet antagonist on the WHO Model List of Essential Medicines. Unlike thienopyridines (clopidogrel, prasugrel), it does not require metabolic bioactivation, offering rapid, predictable, and reversible platelet inhibition. Indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (ACS) or a history of myocardial infarction and high risk of developing an atherothrombotic event.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Ticagrelor.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Ticagrelor Tablets 90 mg | 10's | ₹134.07 | AXCER, BRILINTA, XYGREL, TICAGAT, TICASMART | ₹254.93 | 47% Save |
| Ticagrelor Tablets 60mg | 10's | ₹89.06 | AXCER, BRILINTA, VASOGLOR, TORPLAT, XYGREL | ₹226.83 | 61% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Ticagrelor generics.